8.4 C
New York
Friday, November 20, 2026

Syndromic surveillance to track outbreaks in 70 labs

Must read

Rajiv
Rajivhttps://trendsnewsstories.com/
Rajiv writes and edits news and explainers for Trends News Stories, based in New Delhi, India.

India will track four infectious disease syndromes across 70 laboratories in a new early-warning network for outbreaks, led by the Department of Health Research (DHR) and the Indian Council of Medical Research (ICMR). The syndromic surveillance network was launched at the third DHR-ICMR Health Research Excellence Summit in New Delhi.

The network will use real-time or near-real-time health data to spot possible outbreaks from patterns of symptoms, before laboratory confirmation arrives. It will run through 70 Virus Research and Diagnostic Laboratories (VRDLs) and Infectious Disease Research and Diagnostic Laboratories (IRDLs) across the country. The syndromic surveillance network links those labs into one system for spotting outbreaks early.

The four syndromes under watch

The framework covers acute febrile illness, acute encephalitis syndrome, acute respiratory illness and acute diarrhoeal disease. Acute febrile illness includes acute undifferentiated fever, fever with rash and fever with lymphadenopathy. Acute encephalitis syndrome covers conditions in which the brain becomes inflamed, often linked to infection. Acute respiratory illness covers infections of the breathing passages, and acute diarrhoeal disease covers infections that cause diarrhoea.

ICMR has drawn up syndrome-specific priority pathogen lists to guide doctors, laboratory specialists, epidemiologists and policymakers on testing and surveillance. The lists were built through 44 meetings with clinicians, laboratory specialists and epidemiologists from across the country, and grade pathogens from common to rare and high risk. The lists give the syndromic surveillance network a fixed set of pathogens to test for under each syndrome.

How syndromic surveillance will work

Syndromic surveillance tracks clusters of symptoms such as fever, rash, cough or diarrhoea, and raises an alert when an unusual rise appears in one symptom group. The alert comes before a confirmed diagnosis, so targeted testing and investigation can start sooner. The network will support epidemiological investigations and help authorities judge an outbreak’s scale, geographical spread and speed of transmission.

The approach adds to laboratory-based surveillance rather than replacing it. The same 70-lab network that raises a signal can also confirm it quickly, keeping detection and diagnosis linked. Syndromic surveillance does not replace laboratory confirmation; it brings the alert forward so confirmation can start sooner.

Why syndromic surveillance matters now

COVID-19 showed how much late detection of an outbreak can cost, in lives and in money. Syndromic surveillance moves the alert earlier in the outbreak timeline, from symptom patterns rather than confirmed cases. The network gives health authorities a way to act while cases are still few, instead of waiting for laboratory results to confirm what clinicians already suspect.

The system also builds on laboratories that already exist. The VRDL network has run for years as part of India’s virus research and diagnostic capacity, and the new framework puts its data to a fresh use: watching for the first signs of an outbreak rather than only confirming one after it has spread.

For the system to work, its signals still have to reach the district teams that work under the Integrated Disease Surveillance Programme. That link between the syndromic surveillance network and district response teams is what turns an early signal into action.

Launched alongside two other initiatives

The summit, held on 16 and 17 November at Bharat Mandapam in New Delhi, brought together more than 600 scientists, researchers, innovators, policymakers and administrators, and marked 115 years of ICMR’s work in medical and biomedical research. Two other initiatives were launched there: the DHR Research to Action Vertical, which turns research findings into decision-ready inputs for government policy and public health programmes, and the Dr M.K. Bhan Young Medical Faculty PhD Portal, a central platform for prospective applicants. Syndromic surveillance was the disease-tracking piece of the three initiatives launched at the summit.

The summit also marked a milestone for ICMR’s Medical Innovations Patent Mitra initiative, launched by Union Health Minister J.P. Nadda in March 2025. ICMR has now crossed 100 technology transfer deals in under two years, and 20 licensing agreements covering eight technologies were exchanged with nine Indian companies at the summit. The deals were signed under Medical Innovations Patent Mitra, the ICMR initiative that takes indigenous health innovations from laboratories to practical use.

More articles

Latest article